Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Ticker SymbolINSP
Company nameInspire Medical Systems Inc
IPO dateMay 03, 2018
CEOMr. Timothy P. (Tim) Herbert
Number of employees1246
Security typeOrdinary Share
Fiscal year-endMay 03
Address5500 Wayzata Blvd Ste 1600
CityGOLDEN VALLEY
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code55416-1237
Phone17639575037
Websitehttps://www.inspiresleep.com/
Ticker SymbolINSP
IPO dateMay 03, 2018
CEOMr. Timothy P. (Tim) Herbert
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data